Sitagliptin Phosphate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Sitagliptin Phosphate
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Century Sitagliptin Phosphate

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Sitagliptin Phosphate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

159 API Suppliers, 67 USDMF, 28 CEP/COS, 6 JDMF, 24 EU WC, 6 KDMF, 43 NDC API, 101 Listed Suppliers, $ API Reference Price

159 API Suppliers
67 USDMF
28 CEP/COS
6 JDMF
24 EU WC
6 KDMF
43 NDC API
101 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

54 Intermediate Suppliers

54 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

562 FDF Dossiers, 65 FDA Orange Book, 231 Europe, 80 Australia, 6 South Africa, 180 Listed Dossiers

562 FDF Dossiers
65 FDA Orange Book
231 Europe
80 Australia
6 South Africa
180 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - 1GM;EQ 50MG BASE, TABLET;ORAL - 500MG;EQ 50MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 50MG BASE
TABLET;ORAL - 1GM;EQ 50MG BASE
TABLET;ORAL - 500MG;EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

2 Minakem, 2 SPI Pharma, 2 Seqens, 11 DKSH, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 1 ACG Worldwide, 3 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Coating Systems & Additives, 34 Fillers, Diluents & Binders, 29 Controlled & Modified Release, 22 Lubricants & Glidants, 18 Disintegrants & Superdisintegrants, 16 Thickeners and Stabilizers, 13 Granulation, 12 Direct Compression, 11 Topical, 8 Film Formers & Plasticizers, 7 Co-Processed Excipients, 7 API Stability Enhancers, 7 Solubilizers, 6 Taste Masking, 5 Empty Capsules, 5 Coloring Agents, 5 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Emulsifying Agents, 4 Parenteral, 3 Rheology Modifiers, 1 Surfactant & Foaming Agents

52 Coating Systems & Additives
34 Fillers, Diluents & Binders
29 Controlled & Modified Release
22 Lubricants & Glidants
18 Disintegrants & Superdisintegrants
16 Thickeners and Stabilizers
13 Granulation
12 Direct Compression
11 Topical
8 Film Formers & Plasticizers
7 Co-Processed Excipients
7 API Stability Enhancers
7 Solubilizers
6 Taste Masking
5 Empty Capsules
5 Coloring Agents
5 Chewable & Orodispersible Aids
4 Vegetarian Capsules
4 Emulsifying Agents
4 Parenteral
3 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 136 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
136 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 200 Finished Drug Prices, 17 Annual Reports

2 US Medicaid Prescriptions
200 Finished Drug Prices
17 Annual Reports

MARKET PLACE

43 APIs, 20 FDF Dossiers

43 APIs
20 FDF Dossiers

PATENTS & EXCLUSIVITIES

45 US Patents, 16 US Exclusivities, 9 Health Canada Patents

45 US Patents
16 US Exclusivities
9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 11 Others

2 USP
11 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 567 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

45 All

01 18MERCK SHARP DOHME

02 24MSD SUB MERCK

03 3ZYDUS LIFESCIENCES

filter Patent Number Reset all filters

45 All

01 167326708

02 28080580

03 28414921

04 29308204

05 29439901

06 310925871

07 167326708*PED

08 28414921*PED

filter API Patent Reset all filters

45 All

01 18Y

02 27Blank

filter FDF Patent Reset all filters

45 All

01 25Y

02 20Blank

filter Expiration Date Reset all filters

45 All

01 62026-04-11

02 62026-10-11

03 102026-11-24

04 102027-05-24

05 22028-07-21

06 22029-01-21

07 22030-07-13

08 42030-10-21

09 32035-02-25

drl Sitagliptin Phosphate

Product Main Page

01

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

The Generic Rx Session

Not Confirmed

MERCK SHARP DOHME

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-05-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21995

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!